Sunbelt Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
Sunbelt Securities's AUPH Position: Q1 2026 in Review
Sunbelt Securities held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 2,453 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.
Sunbelt Securities first reported a position in AUPH in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.73M in Q4 2023. 260 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.
- Sunbelt Securities held 2,453 shares of Aurinia Pharmaceuticals worth $36.4K as of Q1 2026.
- Sunbelt Securities left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1107 holding.
- Sunbelt Securities first reported a position in Aurinia Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
- Sunbelt Securities's Aurinia Pharmaceuticals position peaked at $1.73M in Q4 2023.
- 260 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.